Price target
64.890.00 0.00%
The 14 analysts offering 1 year price forecasts for GMED have a max estimate of — and a min estimate of —.
Analyst rating
Based on 17 analysts giving stock ratings to GMED in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
GMED EPS for the last quarter is 0.60 USD despite the estimation of 0.58 USD. In the next quarter EPS is expected to reach 0.57 USD. Track more of Globus Medical, Inc. financials and stay on top of what is up with the company.
In the next quarter Globus Medical, Inc. revenue is expected to reach 586.83 M USD. Check out Globus Medical, Inc. revenue and earnings and make informed decisions.
According to analysts, GMED price target is 64.89 USD with a max estimate of 83.00 USD and a min estimate of 55.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with GMED news and stock market news.
We've gathered opinions of 17 analysts rating GMED stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.